Banner

Biologics Contract Development Global Market Report 2023 – By Source (Microbial, Mammalian, Others Soruces), By Indication (Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications), By Product Service (Cell Line Development, Process Development, Others Product Services) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


Biologics contract development refers to companies that provide biologics development and manufacturing services to pharmaceutical corporations on a contract basis. The biologics contract development is used to outsource the manufacturing of biologics on contracts to focus on the marketing, R&D, and branding of products.

The main source of biologics contract development are microbial, mammalian, and others soruces. The microbial source of biologics contract development are used for the production of various biologics. The biologics contract development indication are oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others indications that are applied in the product service of biologics contract development such as cell line development, process development, and others product services.

The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides biologics contract development market statistics, including biologics contract development industry global market size, regional shares, competitors with a biologics contract development market share, detailed biologics contract development market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. This biologics contract development market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global biologics contract development market size is expected to grow from $6.27 billion in 2022 to $7.00 billion in 2023 at a compound annual growth rate (CAGR) of 11.61%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biologics contract development market size is expected to reach $10.29 billion in 2027 at a CAGR of 10.13%.

The rising prevalence of chronic diseases is expected to propel the biologics contract development market going forward. Chronic diseases refer to an illness that lasts for a year or longer that requires ongoing medical attention. The rise in chronic disease cases is increasing the demand for developing novel drugs, including biologics, thereby promoting the biologics contract development market. For instance, according to data published in April 2021 by the World Health Organization, a Switzerland-based health organization for international public health, 41 million people die every year due to chronic diseases globally, close to 71% of all deaths. Therefore, the rising prevalence of chronic diseases will drive the biologics contract development market.

Technological advancements are gaining popularity in the biologics contract development market. Major companies in the biologics contract development market are integrating advanced technologies to sustain their position in the market. For instance, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, launched bYlok technology platform to design and manufacture bispecific antibodies. It helps to solve the light-heavy chain mispairing issue with high yields, >95% accuracy, and the ability to maintain a mAb-like format. It can be accessed by pharma and biotech companies through a simple research license.

In February 2022, Recipharm, a Sweden-based pharmaceutical contract development and manufacturing organization, acquired Vibalogics and Arranta Bio for an undisclosed amount. This acquisition will strengthen Recipharm’s presence in advanced therapy medicinal products and enable it to expand virotherapy manufacturing capabilities in the US. Vibalogics is a Germany-based contract development and manufacturing organization. Arranta Bio is a US-based contract development and manufacturing organization.

Major players in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc., LakePharma Inc., GenScript, Bionova Scientific Inc., Boehringer Ingelheim BioXcellence, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, and Forge Biologics.

North America was the largest region in the biologics contract development market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global biologics contract development market is segmented -

1) By Source: Microbial, Mammalian, Others Soruces

2) By Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others Indications

3) By Product Service: Cell Line Development, Process Development, Others Product Services

    Table Of Contents

    1. Executive Summary

    2. Biologics Contract Development Market Characteristics

    3. Biologics Contract Development Market Trends And Strategies

    4. Biologics Contract Development Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Biologics Contract Development Market

    4.2. Ukraine-Russia War Impact On Biologics Contract Development Market

    4.3. Impact Of High Inflation On Biologics Contract Development Market

    5. Biologics Contract Development Market Size And Growth

    5.1. Global Biologics Contract Development Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Biologics Contract Development Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Biologics Contract Development Market Segmentation

    6.1. Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Microbial

    Mammalian

    Others Soruces

    6.2. Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Oncology

    Immunological Disorders

    Cardiovascular Disorders

    Hematological Disorders

    Others Indications

    6.3. Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cell Line Development

    Process Development

    Others Product Services

    7. Biologics Contract Development Market Regional And Country Analysis

    7.1. Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Biologics Contract Development Market

    8.1. Asia-Pacific Biologics Contract Development Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Biologics Contract Development Market

    9.1. China Biologics Contract Development Market Overview

    9.2. China Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Biologics Contract Development Market

    10.1. India Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Biologics Contract Development Market

    11.1. Japan Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Biologics Contract Development Market

    12.1. Australia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Biologics Contract Development Market

    13.1. Indonesia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Biologics Contract Development Market

    14.1. South Korea Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Biologics Contract Development Market

    15.1. Western Europe Biologics Contract Development Market Overview

    15.2. Western Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Biologics Contract Development Market

    16.1. UK Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Biologics Contract Development Market

    17.1. Germany Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Biologics Contract Development Market

    18.4. France Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Biologics Contract Development Market

    19.1. Eastern Europe Biologics Contract Development Market Overview

    19.2. Eastern Europe Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Biologics Contract Development Market

    20.1. Russia Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Biologics Contract Development Market

    21.1. North America Biologics Contract Development Market Overview

    21.2. North America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Biologics Contract Development Market

    22.1. USA Biologics Contract Development Market Overview

    22.2. USA Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Biologics Contract Development Market

    23.1. South America Biologics Contract Development Market Overview

    23.2. South America Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Biologics Contract Development Market

    24.1. Brazil Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Biologics Contract Development Market

    25.1. Middle East Biologics Contract Development Market Overview

    25.2. Middle East Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Biologics Contract Development Market

    26.1. Africa Biologics Contract Development Market Overview

    26.2. Africa Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Biologics Contract Development Market Competitive Landscape And Company Profiles

    27.1. Biologics Contract Development Market Competitive Landscape

    27.2. Biologics Contract Development Market Company Profiles

    27.2.1. WuXi Biologics

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Abzena Ltd

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Fujifilm Diosynth Biotechnologies

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. KBI Biopharma

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. AGC Biologics

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Biologics Contract Development Market

    29. Biologics Contract Development Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: China, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: India, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: Japan, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Australia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Indonesia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: South Korea, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: Western Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: UK, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Germany, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: France, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: Eastern Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Russia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: North America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: USA, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: South America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: Brazil, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Middle East, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Africa, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: WuXi Biologics Financial Performance
  • Table 47: Abzena Ltd Financial Performance
  • Table 48: Fujifilm Diosynth Biotechnologies Financial Performance
  • Table 49: KBI Biopharma Financial Performance
  • Table 50: AGC Biologics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Biologics Contract Development Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Biologics Contract Development Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Biologics Contract Development Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: China, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: India, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: Japan, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Australia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Indonesia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: South Korea, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: Western Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: UK, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Germany, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: France, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: Eastern Europe, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Russia, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: North America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: USA, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: South America, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: Brazil, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Middle East, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Africa, Biologics Contract Development Market, Segmentation By Source, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Biologics Contract Development Market, Segmentation By Product Service, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: WuXi Biologics Financial Performance
  • Figure 47: Abzena Ltd Financial Performance
  • Figure 48: Fujifilm Diosynth Biotechnologies Financial Performance
  • Figure 49: KBI Biopharma Financial Performance
  • Figure 50: AGC Biologics Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report